EUVIMEDEUVIMED entdecken
Open Access

Sweetening the Deal: Sweetener-Based Ionic Liquid of Albendazole Significantly Enhances Its Solubility and Oral Bioavailability

Joseph S Adams, Yogesh Sutar, Srushti Mukkirwar, Chirag Miglani, Abhijit A Date iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c01508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Joseph S Adams und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States. Hauptthemen laut MEDLINE: Albendazole, Ionic Liquids, Sweetening Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NASA grant, NSF grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Albendazole (ABZ) is a hydrophobic and weakly basic anthelmintic benzimidazole with a very low (5%) oral bioavailability. Conversion of hydrophobic ionizable drugs such as ABZ into ionic liquids (ILs) or liquid salts is an emerging strategy for improving their solubility and oral bioavailability. To date, FDA-approved non-nutritive anionic sweeteners have not been evaluated for the development of ILs of weakly basic and hydrophobic drugs. Hence, we evaluated the ability of various anionic non-nutritive sweeteners, acesulfame potassium (ACE-K), saccharin sodium (SAC-Na), and cyclamate sodium (CYM-Na), to transform ABZ into an IL. Interestingly, only ACE-K, upon interaction with ABZ at the ABZ to ACE molar ratio of 1:2, converted ABZ into a room-temperature IL [ABZ-ACE (1:2) IL], whereas SAC-Na and CYM-Na yielded salts or coamorphous systems. The interaction of ABZ with anionic sweeteners was confirmed using FT-IR and NMR. Compared to pure ABZ, all ABZ-sweetener ILs/salts/coamorphous systems displayed a 1.2- to 2-fold decrease in Log P value and a significant increase in the equilibrium solubility of ABZ in water, pH 1.2 buffer, and pH 6.8 buffer. ABZ-ACE (1:2) IL exhibited remarkably higher (∼92-fold) solubility in water and ∼5-fold improvement in pH 6.8 buffer solubility, with a complete lack of crystallinity at room temperature, even after 1 month of storage at room temperature. Finally, compared to ABZ oral suspension, orally delivered ABZ-ACE (1:2) IL showed an 11-fold increment in Cmax and a 7.6-fold increase in the oral bioavailability of ABZ in mice. Hence, the development of a sweetener-based IL could be an effective approach to improving the solubility and oral bioavailability of hydrophobic weakly basic drugs, including ABZ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbendazoleIonic LiquidsSweetening AgentsSolubilityBiological AvailabilityAnimalsAdministration, OralMiceMaleHydrophobic and Hydrophilic InteractionsSaccharinThiazines

Stichwörter der Autor:innen

API-ILcoamorphous systemsroom-temperature IL (RT-IL)salt metathesissweetener

Substanzen

AlbendazoleIonic LiquidsSweetening AgentsSaccharinThiazinesacetosulfame

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
  • Department of Ophthalmology and Vision Science, University of Arizona College of Medicine, Tucson, Arizona 85711, United States.

ORCID-Profile: Abhijit A Date

Förderung

  • NIAID NIH HHS
  • NASA grant
  • NSF grant
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Adams, J. S., Sutar, Y., Mukkirwar, S., Miglani, C., & Date, A. A. (2025). Sweetening the Deal: Sweetener-Based Ionic Liquid of Albendazole Significantly Enhances Its Solubility and Oral Bioavailability. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01508

Vancouver

Adams JS, Sutar Y, Mukkirwar S, Miglani C, Date AA. Sweetening the Deal: Sweetener-Based Ionic Liquid of Albendazole Significantly Enhances Its Solubility and Oral Bioavailability. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01508

BibTeX
@article{Adams2025,
  author = {Adams, Joseph S and Sutar, Yogesh and Mukkirwar, Srushti and Miglani, Chirag and Date, Abhijit A},
  title = {Sweetening the Deal: Sweetener-Based Ionic Liquid of Albendazole Significantly Enhances Its Solubility and Oral Bioavailability},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c01508}
}
Kostenlos starten →